CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells - PubMed (original) (raw)
CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells
Leonard J Appleman et al. J Immunol. 2002.
Abstract
CD28 provides a costimulatory signal that cooperates with the TCR/CD3 complex to induce T cell activation, cytokine production, and clonal expansion. We have recently shown that CD28 directly regulates progression of T lymphocytes through the cell cycle. Although a number of signaling pathways have been linked to the TCR/CD3 and to CD28, it is not known how these two receptors cooperate to induce cell cycle progression. Here, using cell-permeable pharmacologic inhibitors of phosphatidylinositol 3-hydroxykinase (PI3K) and mitogen-activated protein kinase kinase (MEK1/2), we show that cell cycle progression of primary T lymphocytes requires simultaneous activation of PI3K- and MEK1/2-dependent pathways. Decreased abundance of cyclin-dependent kinase inhibitor p27(kip1), which requires simultaneous TCR/CD3 and CD28 ligation, was dependent upon both MEK and PI3K activity. Ligation of TCR/CD3, but not CD28 alone, resulted in activation of MEK targets extracellular signal-related kinase 1/2, whereas ligation of CD28 alone was sufficient for activation of PI3K target protein kinase B (PKB; c-Akt). CD28 ligation alone was also sufficient to mediate inactivating phosphorylation of PKB target glycogen synthase kinase-3 (GSK-3). Moreover, direct inactivation of GSK-3 by LiCl in the presence of anti-CD3, but not in the presence of anti-CD28, resulted in down-regulation of p27(kip1), hyperphosphorylation of retinoblastoma tumor suppressor gene product, and cellular proliferation. Thus, inactivation of the PI3K-PKB target GSK-3 could substitute for CD28 but not for CD3 signals. These results show that the PI3K-PKB pathway links CD28 to cell cycle progression and suggest that p27(kip1) integrates mitogenic MEK- and PI3K-dependent signals from TCR and CD28 in primary T lymphocytes.
Similar articles
- CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression.
Appleman LJ, Berezovskaya A, Grass I, Boussiotis VA. Appleman LJ, et al. J Immunol. 2000 Jan 1;164(1):144-51. doi: 10.4049/jimmunol.164.1.144. J Immunol. 2000. PMID: 10605005 - Active protein kinase B regulates TCR responsiveness by modulating cytoplasmic-nuclear localization of NFAT and NF-kappa B proteins.
Patra AK, Na SY, Bommhardt U. Patra AK, et al. J Immunol. 2004 Apr 15;172(8):4812-20. doi: 10.4049/jimmunol.172.8.4812. J Immunol. 2004. PMID: 15067058 - Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.
Liang J, Slingerland JM. Liang J, et al. Cell Cycle. 2003 Jul-Aug;2(4):339-45. Cell Cycle. 2003. PMID: 12851486 Review. - The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3.
Kane LP, Weiss A. Kane LP, et al. Immunol Rev. 2003 Apr;192:7-20. doi: 10.1034/j.1600-065x.2003.00008.x. Immunol Rev. 2003. PMID: 12670391 Review.
Cited by
- Immune microenvironment in papillary thyroid carcinoma: roles of immune cells and checkpoints in disease progression and therapeutic implications.
Zheng X, Sun R, Wei T. Zheng X, et al. Front Immunol. 2024 Sep 3;15:1438235. doi: 10.3389/fimmu.2024.1438235. eCollection 2024. Front Immunol. 2024. PMID: 39290709 Free PMC article. Review. - Rigid crosslinking of the CD3 complex leads to superior T cell stimulation.
Nelson AD, Wang L, Laffey KG, Becher LRE, Parks CA, Hoffmann MM, Galeano BK, Mangalam A, Teixeiro E, White TA, Schrum AG, Cannon JF, Gil D. Nelson AD, et al. Front Immunol. 2024 Aug 30;15:1434463. doi: 10.3389/fimmu.2024.1434463. eCollection 2024. Front Immunol. 2024. PMID: 39281668 Free PMC article. - USP28 protects development of inflammation in mouse intestine by regulating STAT5 phosphorylation and IL22 production in T lymphocytes.
Le Menn G, Pikkarainen K, Mennerich D, Miroszewska D, Kietzmann T, Chen Z. Le Menn G, et al. Front Immunol. 2024 Jul 15;15:1401949. doi: 10.3389/fimmu.2024.1401949. eCollection 2024. Front Immunol. 2024. PMID: 39076972 Free PMC article. - PD-L1's Role in Preventing Alloreactive T Cell Responses Following Hematopoietic and Organ Transplant.
Handelsman S, Overbey J, Chen K, Lee J, Haj D, Li Y. Handelsman S, et al. Cells. 2023 Jun 12;12(12):1609. doi: 10.3390/cells12121609. Cells. 2023. PMID: 37371079 Free PMC article. Review. - Immune checkpoint inhibitor-associated toxicity in advanced non-small cell lung cancer: An updated understanding of risk factors.
Hu X, Wang L, Shang B, Wang J, Sun J, Liang B, Su L, You W, Jiang S. Hu X, et al. Front Immunol. 2023 Mar 6;14:1094414. doi: 10.3389/fimmu.2023.1094414. eCollection 2023. Front Immunol. 2023. PMID: 36949956 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous